EUVIMEDEUVIMED entdecken
Open Access

Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model

Huynh Quang Dieu Nguyen, Mi-Hyun Nam, Jozsef Vigh, Joseph Brzezinski, Lucas Duncan, Daewon Park

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.06.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Huynh Quang Dieu Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, 2115 N. Scranton St, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Zinc, Chelating Agents, Optic Nerve Injuries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, Research to Prevent Blindness, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic optic neuropathies lead to retinal ganglion cell (RGC) death and axonal degeneration, primarily due to disrupted neurotrophic factor (NTF) supply from the brain and a neurotoxic cascade, potentially mediated by elevated retinal Zn²⁺ levels. Ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) are two major NTFs known to support RGC survival and axon protection. Dipicolylamine (DPA), a Zn²⁺ chelator with high selectivity and affinity, offers a strategy to reduce excess Zn²⁺. To achieve sustained NTF delivery and Zn²⁺ reduction, we developed sulfonated poly(serinol hexamethylene urea) nanoparticles (S-PSHU NPs) co-loaded with CNTF, BDNF, and DPA. In vitro release studies demonstrated sustained release of CNTF and BDNF for up to 8 weeks and DPA for up to 4 weeks. In a rat optic nerve crush (ONC) model, DPA-loaded S-PSHU NPs showed dose-dependent elimination of retinal Zn²⁺. Additionally, in primary RGC culture, RGC activity and axon growth correlated with CNTF and BDNF dosage. In vivo, NTF-DPA-loaded S-PSHU NPs significantly enhanced RGC survival and axon protection post-ONC, as evidenced by cholera toxin subunit B (CTB)-labeled axons in the central visual centers of the brain, including the suprachiasmatic nucleus, lateral geniculate nucleus, and superior colliculus. STATEMENT OF SIGNIFICANCE: • Co-delivery of neurotrophic factors (NTFs: CNTF and BDNF) and a zinc chelator (dipicolylamine, DPA) promotes retinal ganglion cell (RGC) axon survival and protection. • Sustained release of NTFs for up to 8 weeks and DPA for up to 4 weeks. • DPA-loaded nanoparticles effectively eliminate excess retinal zinc after optic nerve injury. • NTF-DPA-loaded nanoparticles significantly improve RGC survival and axon protection in a rat optic nerve crush model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsZincChelating AgentsOptic Nerve InjuriesAxonsNerve Growth FactorsAnimalsCell SurvivalRats, Sprague-DawleyBrain-Derived Neurotrophic FactorNerve CrushRatsDisease Models, AnimalMaleNeuroprotective AgentsNanoparticlesCiliary Neurotrophic FactorPicolinic Acids

Stichwörter der Autor:innen

Axon protectionNeurotrophic factorRetinal ganglion cellSulfonated nanoparticlesZinc chelator

Substanzen

ZincChelating AgentsBrain-Derived Neurotrophic FactorNerve Growth FactorsNeuroprotective AgentsCiliary Neurotrophic FactorPicolinic Acids

Autor:innen und Institutionen

  • Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, 2115 N. Scranton St, Aurora, CO 80045, USA.
  • Department of Ophthalmology, University of Colorado School of Medicine, 1675 Aurora Court, Aurora, CO 80045, USA.
  • Department of Biomedical Science, Colorado State University, 1617 Campus Delivery, Fort Collins, CO 80523, USA.
  • Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, 2115 N. Scranton St, Aurora, CO 80045, USA; Department of Ophthalmology, University of Colorado School of Medicine, 1675 Aurora Court…

Förderung

  • NEI NIH HHS
  • Research to Prevent Blindness
  • National Institutes of Health

Zitieren

APA

Nguyen, H. Q. D., Nam, M. H., Vigh, J., Brzezinski, J., Duncan, L., & Park, D. (2025). Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.06.007

Vancouver

Nguyen HQD, Nam MH, Vigh J, Brzezinski J, Duncan L, Park D. Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.06.007

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Huynh Quang Dieu and Nam, Mi-Hyun and Vigh, Jozsef and Brzezinski, Joseph and Duncan, Lucas and Park, Daewon},
  title = {Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.06.007}
}
Kostenlos starten →